Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. 2006

Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
Department of Pediatrics, University of Brescia Spedali Civili, Italy.

Although relatively rare, primary immunodeficiency diseases (PIDs) provide an excellent window into the functioning of the immune system. In the late 1960s, observations on these diseases, with their associated infections and genetics, bisected the immune system into humoral immunity and cell-mediated immunity. These diseases also represent a challenge in their diagnosis and treatment. Beginning in 1970, a unified nomenclature for the then-known PIDs was created by a committee convoked by the World Health Organization. Since then, and later under the aegis of the International Union of Immunological Societies, an international committee of experts has met every 2 to 3 years to update the classification of PIDs. During the past 15 years, the molecular basis of more than 120 PIDs has been elucidated. This update results from the latest meeting of this committee in Budapest, Hungary, in June 2005, which followed 2 1/2 days of scientific discussions. As a result of this work, new entities have been included, and the nomenclature of some PIDs (specifically of the various forms of class-switch recombination defects, previously known as hyper-IgM syndromes) has been changed.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D009626 Terminology as Topic Works about the terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area. Etymology,Nomenclature as Topic,Etymologies
D010586 Phagocytes Cells that can carry out the process of PHAGOCYTOSIS. Phagocyte,Phagocytic Cell,Phagocytic Cells,Cell, Phagocytic,Cells, Phagocytic
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006814 Hungary A country in Europe, northwest of Romania, south of Slovakia, and east of Austria. The capital is Budapest.
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
January 2014, Frontiers in immunology,
Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
November 2015, Journal of clinical immunology,
Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
April 2012, Clinical and experimental immunology,
Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
October 1999, Clinical and experimental immunology,
Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
January 2018, Journal of clinical immunology,
Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
June 2020, Indian pediatrics,
Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
October 2022, Journal of clinical immunology,
Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
January 2020, Journal of clinical immunology,
Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
January 2020, Journal of clinical immunology,
Luigi Notarangelo, and Jean-Laurent Casanova, and Mary Ellen Conley, and Helen Chapel, and Alain Fischer, and Jennifer Puck, and Chaim Roifman, and Reinhard Seger, and Raif S Geha, and
December 1988, Cellular immunology,
Copied contents to your clipboard!